Comparative Efficacy of Ormeloxifene Versus Norethisterone Acetate in the Management of Abnormal Uterine Bleeding: A Randomized Controlled Trial.

Adverse effects At six months, a total of seven (23.3%) women in the Ormeloxifene group and two (6.7%) women in the norethisterone group reported side effects, though this difference did not reach statistical significance (chi-square with Yates correction value = 2.09, p = 0.148).

also in 111,027 other papers

Substantial reductions in menstrual blood loss were seen in both groups, but decreases were consistently greater and highly significant for ormeloxifene at each follow-up (Figure 3 ).

also in 132,142 other papers